Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600771'
s EV-to-FCF Range Over the Past 10 Years
Min: -915.27 Med: -15.29 Max: 410.12
Current: 39.86
During the past 13 years, the highest EV-to-FCF of GuangYuYuan Chinese Herbal Medicine Co was 410.12. The lowest was -915.27. And the median was -15.29.
SHSE:600771's EV-to-FCF is ranked worse than 68.44% of 564
companies
in the Drug Manufacturers industry
Industry Median: 20.815
vs SHSE:600771: 39.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GuangYuYuan Chinese Herbal Medicine Co's PE Ratio (TTM) for today is calculated as:
GuangYuYuan Chinese Herbal Medicine Co's share price for today is ¥15.04.
GuangYuYuan Chinese Herbal Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.136.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
GuangYuYuan Chinese Herbal Medicine Co EV-to-FCF Related Terms
GuangYuYuan Chinese Herbal Medicine Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GuangYuYuan Chinese Herbal Medicine Co EV-to-FCF Chart
GuangYuYuan Chinese Herbal Medicine Co Annual Data
SHSE:600771 vs LLY, JNJ, ABBV: EV-to-FCF Comparison
For the Drug Manufacturers - General subindustry, GuangYuYuan Chinese Herbal Medicine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GuangYuYuan Chinese Herbal Medicine Co EV-to-FCF vs Drug Manufacturers Industry
GuangYuYuan Chinese Herbal Medicine Co's current Enterprise Value is ¥7,394 Mil.
GuangYuYuan Chinese Herbal Medicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥170 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) has a EV-to-FCF of 43.55 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on GuangYuYuan Chinese Herbal Medicine Co and its competitors. According to the industry distribution chart, GuangYuYuan Chinese Herbal Medicine Co ranks #386 out of 564 companies in the Drug Manufacturers industry, placing it in the top 68.4%.
Is GuangYuYuan Chinese Herbal Medicine Co's EV-to-FCF too high?
GuangYuYuan Chinese Herbal Medicine Co's current EV-to-FCF is 43.55. The Drug Manufacturers industry median EV-to-FCF is 20.82. GuangYuYuan Chinese Herbal Medicine Co's value of 43.55 is 109.2% above this industry median. Based on the distribution chart, GuangYuYuan Chinese Herbal Medicine Co ranks #386 out of 564 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, GuangYuYuan Chinese Herbal Medicine Co has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GuangYuYuan Chinese Herbal Medicine Co's EV-to-FCF compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GuangYuYuan Chinese Herbal Medicine Co ranks #386 out of 564 companies for EV-to-FCF. This places GuangYuYuan Chinese Herbal Medicine Co in the lower half of its industry. The industry median EV-to-FCF is 20.82. GuangYuYuan Chinese Herbal Medicine Co's value of 43.55 is 109.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.82, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GuangYuYuan Chinese Herbal Medicine Co's current EV-to-FCF of 43.55 is 109.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on GuangYuYuan Chinese Herbal Medicine Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GuangYuYuan Chinese Herbal Medicine Co's current EV-to-FCF is 43.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuangYuYuan Chinese Herbal Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥24.06, compared to a current price of ¥15.04 — trading 37.5% below its estimated fair value. The current EV-to-FCF is 43.55 and 109.2% above the Drug Manufacturers industry median of 20.82. GuangYuYuan Chinese Herbal Medicine Co's overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771), the current EV-to-FCF is 43.55 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GuangYuYuan Chinese Herbal Medicine Co (SHSE:600771) Overvalued in 2026?
Based on GuruFocus' analysis, GuangYuYuan Chinese Herbal Medicine Co stock appears to be undervalued.
The current stock price of ¥15.04 is trading 37.5% below its estimated GF Value™ of ¥24.06.
GuruFocus considers GuangYuYuan Chinese Herbal Medicine Co to be Significantly Undervalued.
Key valuation signals for SHSE:600771:
EV-to-FCF: 43.55
GF Value™: ¥24.06 vs. price of ¥15.04 (37.5% below fair value)
Industry Position: 109.2% above the Drug Manufacturers median (#386 of 564)
No single metric tells the full story. See the SHSE:600771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GuangYuYuan Chinese Herbal Medicine Co Business Description
GuangYuYuan Chinese Herbal Medicine Co Ltd distributes pharmaceutical products. Its products include far plate turtle age wine bottle, niuhuang qingxin pills, boutique angong niuhuang wan, modified turtle age wine, ding kundan, and many more.
52GF Score
Get the complete analysis for SHSE:600771
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600771 has been successfully added to your 
